Treatment failure in hepatitis C: Mechanisms of non-response, Journal of Hepatology, vol.50, issue.2 ,
DOI : 10.1016/j.jhep.2008.11.010
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection, New England Journal of Medicine, vol.360, issue.18, pp.1839-1850, 2009. ,
DOI : 10.1056/NEJMoa0807650
URL : https://hal.archives-ouvertes.fr/inserm-00385235
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies, Hepatology, vol.7, issue.1, pp.17-24, 2008. ,
DOI : 10.1002/hep.21959
Host neutralizing responses and pathogenesis of hepatitis C virus infection, Hepatology, vol.5, issue.1, pp.299-307, 2008. ,
DOI : 10.1002/hep.22307
URL : https://hal.archives-ouvertes.fr/inserm-00395783
Hepatitis C Virus Entry, Journal of Biological Chemistry, vol.283, issue.7, pp.3689-3693, 2008. ,
DOI : 10.1074/jbc.R700024200
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction, Journal of Virology, vol.80, issue.21, pp.10579-10590, 2006. ,
DOI : 10.1128/JVI.00941-06
Binding of Hepatitis C Virus to CD81, Science, vol.282, issue.5390, pp.938-941, 1998. ,
DOI : 10.1126/science.282.5390.938
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, The EMBO Journal, vol.269, issue.19, pp.5017-5025, 2002. ,
DOI : 10.1093/emboj/cdf529
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, vol.23, issue.7137, pp.801-805, 2007. ,
DOI : 10.1038/nature05654
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells, Nature, vol.309, issue.7231, pp.882-886, 2009. ,
DOI : 10.1038/nature07684
Pharmacokinetics and pharmacodynamics: Maximizing the clinical potential of Erlotinib (Tarceva), Seminars in Oncology, vol.30, issue.3, pp.25-33, 2003. ,
DOI : 10.1016/S0093-7754(03)70012-8
Erlotinib in Previously Treated Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.353, issue.2 ,
DOI : 10.1056/NEJMoa050753
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer, Nature Chemical Biology, vol.14, issue.4, pp.291-299, 2010. ,
DOI : 10.1038/nchembio.332
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, The Journal of Experimental Medicine, vol.119, issue.9, pp.2019-2031, 2010. ,
DOI : 10.1073/pnas.0503596102
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells, Journal of Virology, vol.83, issue.12 ,
DOI : 10.1128/JVI.00246-09
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687400
Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor, Cell, vol.110, issue.6, pp.669-672, 2002. ,
DOI : 10.1016/S0092-8674(02)00966-2
Response to transforming growth factor ?? (TGF??) and epidermal growth factor (EGF) in hepatocytes: Lower EGF receptor affinity of TGF?? is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis, Journal of Cellular Physiology, vol.60, issue.1, pp.10-18, 1998. ,
DOI : 10.1002/(SICI)1097-4652(199804)175:1<10::AID-JCP2>3.0.CO;2-F
Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential
HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains, PLoS Pathogens, vol.100, issue.2, p.1000310, 2009. ,
DOI : 10.1371/journal.ppat.1000310.s005
URL : http://doi.org/10.1371/journal.ppat.1000310
Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations, Hepatology, vol.79, issue.4, pp.1144-1157, 2010. ,
DOI : 10.1002/hep.23445
URL : https://hal.archives-ouvertes.fr/inserm-00705657
Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses, Journal of Virology, vol.80, issue.11, pp.5308-5320, 2006. ,
DOI : 10.1128/JVI.02460-05
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.279, issue.6, pp.1722-1731, 2007. ,
DOI : 10.1002/hep.21994
URL : https://hal.archives-ouvertes.fr/inserm-00395706
High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI, Journal of Biological Chemistry, vol.281, issue.27 ,
DOI : 10.1074/jbc.M602706200
URL : https://hal.archives-ouvertes.fr/hal-00313930
Claudin Association with CD81 Defines Hepatitis C Virus Entry, Journal of Biological Chemistry, vol.285, issue.27 ,
DOI : 10.1074/jbc.M110.104836
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898367
CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry, Journal of Virology, vol.82, issue.10, pp.5007-5020, 2008. ,
DOI : 10.1128/JVI.02286-07
Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus, Journal of Virology, vol.81, issue.16, pp.8752-8765, 2007. ,
DOI : 10.1128/JVI.02642-06
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells, Journal of General Virology, vol.90, issue.1, pp.48-58, 2009. ,
DOI : 10.1099/vir.0.006700-0
Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice, Journal of Hepatology, vol.51, issue.6 ,
DOI : 10.1016/j.jhep.2009.09.002
Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor, Journal of General Virology, vol.91, issue.7, pp.1668-1677, 2010. ,
DOI : 10.1099/vir.0.019315-0
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera, Hepatology, vol.158, issue.4, pp.847-856, 2005. ,
DOI : 10.1002/hep.20657
Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models, Anti-Cancer Drugs, vol.15, issue.5, pp.503-512, 2004. ,
DOI : 10.1097/01.cad.0000127664.66472.60
The epidermal growth factor receptor ligands at a glance, Journal of Cellular Physiology, vol.282, issue.3, pp.460-466, 2009. ,
DOI : 10.1002/jcp.21635
Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?, Science Signaling, vol.1, issue.15, p.2, 2008. ,
DOI : 10.1126/stke.115re2
Epidermal Growth Factor Receptor Activation Differentially Regulates Claudin Expression and Enhances Transepithelial Resistance in Madin-Darby Canine Kidney Cells, Journal of Biological Chemistry, vol.279, issue.5, pp.3543-3552, 2004. ,
DOI : 10.1074/jbc.M308682200
Control of tight junctional sealing: roles of epidermal growth factor and prostaglandin E2, AJP: Cell Physiology, vol.297, issue.3, pp.611-620, 2009. ,
DOI : 10.1152/ajpcell.00622.2008
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis, Journal of Virology, vol.80, issue.14 ,
DOI : 10.1128/JVI.00024-06
URL : https://hal.archives-ouvertes.fr/hal-00105504
A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor, Nucleic Acids Research, vol.24, issue.20, pp.4050-4056, 1996. ,
DOI : 10.1093/nar/24.20.4050
URL : https://hal.archives-ouvertes.fr/in2p3-00024414
Transactivation of the Epidermal Growth Factor Receptor in Colonic Epithelial Cells by Carbachol Requires Extracellular Release of Transforming Growth Factor-alpha, Journal of Biological Chemistry, vol.277, issue.45, pp.42603-42612, 2002. ,
DOI : 10.1074/jbc.M206487200
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt, Cancer Cell, vol.16, issue.1, pp.9-20, 2009. ,
DOI : 10.1016/j.ccr.2009.04.009
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.6025-6030, 2007. ,
DOI : 10.1073/pnas.0607026104
URL : https://hal.archives-ouvertes.fr/inserm-00395910
Modeling oncogene addiction using RNA interference, Proceedings of the National Academy of Sciences, vol.105, issue.34 ,
DOI : 10.1073/pnas.0803217105
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2517605
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003. ,
DOI : 10.1093/emboj/21.12.2893
URL : https://hal.archives-ouvertes.fr/inserm-00133783
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proceedings of the National Academy of Sciences, vol.103, issue.19, pp.7408-7413, 2006. ,
DOI : 10.1073/pnas.0504877103
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus, Hepatology, vol.82, issue.2, pp.265-274, 2005. ,
DOI : 10.1002/hep.20542
Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors, Blood, vol.114, issue.15, pp.3173-3180, 2009. ,
DOI : 10.1182/blood-2009-05-220798
Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates, Blood, vol.100, issue.3, pp.823-832, 2002. ,
DOI : 10.1182/blood-2001-11-0042
Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes, Gastroenterology, vol.139, issue.3, pp.953-964, 2010. ,
DOI : 10.1053/j.gastro.2010.05.073
URL : https://hal.archives-ouvertes.fr/inserm-00741442
Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus, Journal of Virology, vol.82, issue.2, pp.966-973, 2008. ,
DOI : 10.1128/JVI.01872-07
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line, Science, vol.285, issue.5424, pp.110-113, 1999. ,
DOI : 10.1126/science.285.5424.110
Distinct roles for cyclin-dependent kinases in cell cycle control, Science, vol.262, issue.5142, pp.2050-2054, 1993. ,
DOI : 10.1126/science.8266103
Negative regulation of EphA2 receptor by Cbl, Biochemical and Biophysical Research Communications, vol.296, issue.1 ,
DOI : 10.1016/S0006-291X(02)00806-9
Simultaneous quantification of erlotinib, gefitinib, and imatinib in human plasma by liquid chromatography tandem mass spectrometry, Ther. Drug Monit, vol.31, pp.683-687, 2009. ,
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983. ,
DOI : 10.1016/0022-1759(83)90303-4